Abstract
The article is dedicated to analyzing the outcomes of an open prospective study of efficacy of Liprimai administered in the postoperative period. The study comprised a total of 30 patients presenting with atherosclerotic lesions of the arteries of the carotid bed and aorto-femoral segment, who were subjected to reconstructive vascular operations. The aim of the present study was to look into a possibility of preventing cardiac complications in patients after endured reconstructive vascular surgery. Liprimar was administered at a daily dose of 10 mg seven days prior to the operation, and for eight days thereafter.
Publication types
-
Clinical Trial
-
English Abstract
MeSH terms
-
Aged
-
Anticholesteremic Agents / administration & dosage
-
Anticholesteremic Agents / therapeutic use*
-
Carotid Artery Diseases / mortality
-
Carotid Artery Diseases / surgery*
-
Cholesterol / blood
-
Diabetes Mellitus, Type 2 / epidemiology
-
Drug Administration Schedule
-
Female
-
Humans
-
Hypertension / epidemiology
-
Leriche Syndrome / mortality
-
Leriche Syndrome / prevention & control
-
Male
-
Middle Aged
-
Postoperative Care*
-
Postoperative Complications / prevention & control*
-
Preoperative Care*
-
Prospective Studies
-
Severity of Illness Index
-
Vascular Surgical Procedures / methods*
Substances
-
Anticholesteremic Agents
-
Cholesterol